DOI QR코드

DOI QR Code

Effects of Sinetrol-XPur on Leptin-Deficient Obese Mice and Activation of cAMP-Dependent UCP-2

Leptin 유전자 결핍 동물모델을 이용한 시네트롤(Sinetrol-XPur)의 항비만 효과와 cAMP를 통한 UCP-2 활성화 기전 연구

  • 유재명 (경희대학교 동서의학대학원) ;
  • 이민희 (경희대학교 동서의학대학원) ;
  • 권한올 (경희대학교 동서의학대학원) ;
  • 최세규 ((주)알피코프) ;
  • 배문형 ((주)알피코프) ;
  • 김옥경 (전남대학교 식품영양과학부)
  • Received : 2015.12.21
  • Accepted : 2016.01.06
  • Published : 2016.04.30

Abstract

The present study investigated the effect of Sinetrol-XPur (polyphenolic Citrus spp. and Paullinia cupana Kunth dry extract) and defined the action mode for cyclic adenosine monophosphate (cAMP)-dependent uncoupling protein (UCP)-2 activation. Leptin-deficient obese mice were treated with two different doses, 100 mg/kg body weight (BW) and 300 mg/kg BW of each AIN93G supplement, for 7 weeks. Treatment of obese mice with both low and high doses of Sinetrol-XPur significantly reduced body weight gain compared to control obese mice. White adipose tissue weight of mice was reduced by 30.96% in high dose-supplemented groups. Serum total cholesterol and triglyceride were reduced by a high dose of Sinetrol-XPur by 20.02% and 30.96%, respectively. Serum level of high density lipoprotein (HDL) was significantly increased by treatment with both doses, as the ratio of HDL to low density lipoprotein increased by 138.78% and 171.49%, respectively. Regarding expression of biochemical factors related to lipid metabolism, fatty acid synthase significantly decreased and UCP-2 increased upon treatment with a high dose of Sinetrol-XPur, but there was no significant difference in lipoprotein lipase and hormone-sensitive lipase. To define cellular mechanism, intracellular cAMP levels in 3T3-L1 adipocytes significantly increased in a dose-dependent manner over the range of $50{\sim}250{\mu}m/mL$. The phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine clearly blocked cAMP, suggesting that Sinetrol-XPur promotes lipolysis of adipocytes through inhibition of cAMP-dependent PDE, resulting in induction of cAMP response element binding protein and UCP-2. These results suggest that Sinetrol-XPur supplementation is a viable option for reducing body weight and fat by improving serum lipid profiles and genetic expression of lipid metabolic factors, especially activation of cAMP-dependent UCP-2.

본 연구에서는 시네트롤(Sinetrol-XPur)을 유전성 비만 마우스(Obese)에 7주간 식이 투여하여 항비만 효과를 알아보고자 하였다. 시네트롤을 섭취한 유전성 비만 마우스군(Sinetrol low와 Sinetrol high)의 체중증가량은 Obese군에 비하여 유의적으로 감소하였고, 간 무게변화량은 Sinetrol high군에서 Obese군보다 유의적으로 감소하였다. 백색지방의 무게변화량은 Sinetrol high군에서 Obese군보다 유의적으로 감소하였음을 확인하였다. 실험동물의 혈청 지질 함량은 TC, TG, LDL/VLDL-콜레스테롤이 Obese군에 비해 Sinetrol군에서 감소하였고, HDL-콜레스테롤은 유전성 비만군(Obese, Sinetrol low, Sinetrol high) 간에 유의적인 차이가 나타나지 않았다. HDL/LDL ratio를 계산한 결과에서는 Sinetrol군에서 Obese군보다 유의적으로 증가하였음을 확인하였다. 실험동물군의 지방조직에서 비만 관련 유전자들의 발현을 측정한 결과, FAS와 LPL의 발현은 Obese군보다 Sinetrol군에서 감소하였고 HSL의 발현은 유의적인 차이가 나타나지 않았지만, UCP-2의 발현은 Obese군에 비해 Sinetrol high군에서 유의적으로 증가하였음을 확인하였다. 또한 세포 내 cAMP를 측정한 결과 시네트롤 처리 시 농도 의존적으로 cAMP가 증가하였음을 확인하였고, 증가한 cAMP에 의해 UCP-2의 발현이 증가되는 것을 확인하였다. 이러한 결과로부터 시네트롤이 지방 합성과 관련된 유전자 발현의 억제 및 에너지 소비와 관련된 유전자의 발현을 증가시키고 체내 지방의 축적이나 합성을 감소시켜 체중의 증가를 예방하며, 혈중 지질 함량들을 개선하여 항비만 효과가 있는 천연 기능성 식품으로 활용할 수 있을 것으로 기대할 수 있다.

Keywords

References

  1. Ingalls AM, Dickie MM, Snell GD. 1996. Obese, a new mutation in the house mouse. Obes Res 4: 101. https://doi.org/10.1002/j.1550-8528.1996.tb00519.x
  2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432. https://doi.org/10.1038/372425a0
  3. Inui A. 2001. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2: 551-560. https://doi.org/10.1038/35086018
  4. Xiong Y, Qu Z, Chen N, Gong H, Song M, Chen X, Du J, Xu C. 2014. The local corticotropin-releasing hormone receptor 2 signalling pathway partly mediates hypoxia-induced increases in lipolysis via the cAMP-protein kinase A signalling pathway in white adipose tissue. Mol Cell Endocrinol 392: 106-114. https://doi.org/10.1016/j.mce.2014.05.012
  5. Aubert J, Champigny O, Saint-Marc P, Negrel R, Collins S, Ricquier D, Ailhaud G. 1997. Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochem Biophys Res Commun 238: 606-611. https://doi.org/10.1006/bbrc.1997.7348
  6. Cho YS, Jang EM, Jang SM, Chun MS, Shon MY, Kim MJ, Lee MK. 2007. Effect of grape seed water extract on lipid metabolism and erythrocyte antioxidant defense system in high-fat diet-induced obese C57BL/6 mice. J Korean Soc Food Sci Nutr 36: 1537-1543. https://doi.org/10.3746/jkfn.2007.36.12.1537
  7. Chen D, Daniel KG, Kuhn DJ, Kazi A, Bhuiyan M, Li L, Wang Z, Wan SB, Lam WH, Chan TH, Dou QP. 2004. Green tea and tea polyphenols in cancer prevention. Front Biosci 9: 2618-2631. https://doi.org/10.2741/1421
  8. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457. https://doi.org/10.1016/0140-6736(93)90206-V
  9. Kuppusamy UR, Das NP. 1992. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 44: 1307-1315. https://doi.org/10.1016/0006-2952(92)90531-M
  10. Kopelman PG. 2000. Obesity as a medical problem. Nature 404: 635-643. https://doi.org/10.1038/35007508
  11. Dallas C, Gerbi A, Elbez Y, Caillard P, Zamaria N, Cloarec M. 2014. Clinical study to assess the efficacy and safety of a citrus polyphenolic extract of red orange, grapefruit, and orange (Sinetrol-XPur) on weight management and metabolic parameters in healthy overweight individuals. Phytother Res 28: 212-218. https://doi.org/10.1002/ptr.4981
  12. Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX. 2008. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMPphosphodiesterase (PDE). Phytomedicine 15: 783-792. https://doi.org/10.1016/j.phymed.2008.05.006
  13. Chae MH, No JG, Jhon DY. 2007. Hangbisan sulfur-based oriental medicine, lowers the blood cholesterol level of ob/ ob obese mice. J Korean Soc Food Sci Nutr 36: 27-31. https://doi.org/10.3746/jkfn.2007.36.1.027
  14. Chua S, Leibel RL. 1997. Obesity genes: Molecular and metabolic mechanism. Diabetes Rev 5: 2-7.
  15. Visscher TL, Seidell JC. 2001. The public health impact of obesity. Annu Rev Public Health 22: 355-375. https://doi.org/10.1146/annurev.publhealth.22.1.355
  16. Kim AR, Hwang YG, Lee JJ, Jung HO, Lee MY. 2011. Effects of Eriobotrya japonica Lindl. (loquat) leaf ethanol extract on cholesterol and antioxidative activity in rats fed a high-fat/high-cholesterol diet. J Korean Soc Food Sci Nutr 40: 673-681. https://doi.org/10.3746/jkfn.2011.40.5.673
  17. Park PJ, Kim CW, Cho SY, Pha CS, Seo DB, Lee SJ. 2010. Aqueous spray-dried green tea extract regulates body weight and epididymal fat accumulation in mice. Korean J Food Sci Technol 42: 103-108.
  18. Lee JS, Lee MK, Ha TY, Bok SH, Park HM, Jeong KS, Woo MN, Do GM, Yeo JY, Choi MS. 2006. Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem Toxicol 44: 1875-1883. https://doi.org/10.1016/j.fct.2006.06.014
  19. Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A, Shimamoto T, Iso H. 2011. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS). Prev Med 52: 381-386. https://doi.org/10.1016/j.ypmed.2011.02.019
  20. Cook NC, Samman S. 1996. Flavonoids-Chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 7: 66-76. https://doi.org/10.1016/0955-2863(95)00168-9
  21. Kim HK, Jeong TS, Lee MK, Park YB, Choi MS. 2003. Lipid-lowering efficacy of hesperetin metabolites in highcholesterol fed rats. Clin Chim Acta 327: 129-137. https://doi.org/10.1016/S0009-8981(02)00344-3
  22. Ronnett GV, Kim EK, Landree LE, Tu Y. 2005. Fatty acid metabolism as a target for obesity treatment. Physiol Behav 85: 25-35. https://doi.org/10.1016/j.physbeh.2005.04.014
  23. Auwerx J, Leroy P, Schoonjans K. 1992. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci 29: 243-268. https://doi.org/10.3109/10408369209114602
  24. Lee JJ, Chung CS, Kim JG, Choi BD. 2000. Effects of fasting- refeeding on rat adipose tissue lipoprotein lipase activity and lipogenesis: influence of food restriction during refeeding. J Korean Soc Food Sci Nutr 29: 471-748.
  25. Langin D, Holm C, Lafontan M. 1996. Adipocyte hormonesensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc 55: 93-109. https://doi.org/10.1079/PNS19960013
  26. Steinberg D, Khoo JC. 1977. Hormone-sensitive lipase of adipose tissue. Fed Proc 36: 1986-1990.
  27. Conti AC, Blendy JA. 2004. Regulation of antidepressant activity by cAMP response element binding proteins. Mol Neurobiol 30: 143-155. https://doi.org/10.1385/MN:30:2:143
  28. Johannessen M, Delghandi MP, Moens U. 2004. What turns CREB on?. Cell Signal 16: 1211-1227. https://doi.org/10.1016/j.cellsig.2004.05.001
  29. Puigserver P, Herron D, Gianotti M, Palou A, Cannon B, Nedergaard J. 1992. Induction and degradation of the uncoupling protein thermogenin in brown adipocytes in vitro and in vivo. Evidence for a rapidly degradable pool. Biochem J 284: 393-398. https://doi.org/10.1042/bj2840393
  30. Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB. 1997. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 235: 79-82. https://doi.org/10.1006/bbrc.1997.6740
  31. Gong DW, He Y, Karas M, Reitman M. 1997. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, ${\beta}3-adrenergic agonists, and leptin. J Biol Chem 272: 24129-21432. https://doi.org/10.1074/jbc.272.39.24129
  32. Yanovski JA, Diament AL, Sovik KN, Nguyen TT, Li H, Sebring NG, Warden CH. 2000. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, Caucasian, and Asian children. Am J Clin Nutr 71: 1405-1420. https://doi.org/10.1093/ajcn/71.6.1405

Cited by

  1. Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial vol.23, pp.3, 2016, https://doi.org/10.1089/jmf.2019.4649